Compare EMBC & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EMBC | ERC |
|---|---|---|
| Founded | 1924 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 279.9M | 258.7M |
| IPO Year | 2021 | N/A |
| Metric | EMBC | ERC |
|---|---|---|
| Price | $5.93 | $8.66 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 57.9K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | 6.88% | ★ 8.37% |
| EPS Growth | ★ 20.90 | N/A |
| EPS | ★ 1.03 | 0.72 |
| Revenue | N/A | N/A |
| Revenue This Year | $1.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $5.46 | $12.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $8.61 |
| 52 Week High | $14.91 | $9.78 |
| Indicator | EMBC | ERC |
|---|---|---|
| Relative Strength Index (RSI) | 68.28 | 21.46 |
| Support Level | $4.84 | N/A |
| Resistance Level | $5.91 | $9.28 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 97.64 | 6.45 |
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.